Universe Pharmaceuticals (UPC) Other Non-Current Assets (2022 - 2024)
Universe Pharmaceuticals (UPC) posted Other Non-Current Assets of -$96326.0 for Q1 2024, down 368.59% sequentially from $35864.0 in Q3 2023, and down 103.95% YoY from $2.4 million in Q2 2023.
Universe Pharmaceuticals (UPC) Other Non-Current Assets (2022 - 2024) Analysis & Trends
Universe Pharmaceuticals has reported Other Non-Current Assets for 3 years, with the latest figure at -$96326.0 in Q1 2024.
- Quarterly Other Non-Current Assets fell 103.95% year-over-year to -$96326.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was -$96326.0 (down 103.95% YoY) and the FY2023 annual result came in at $35864.0, down 98.53% from the prior year.
- Other Non-Current Assets eased to -$96326.0 in Q1 2024 per UPC's latest filing, from $35864.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $2.4 million in Q3 2022 and troughed at -$96326.0 in Q1 2024.
- A 3-year average of $1.2 million and a median of $1.2 million in 2022 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets slumped 98.53% in 2023, then tumbled 103.95% in 2024.
- Over 3 years, Other Non-Current Assets stood at $2.4 million in 2022, then plunged by 98.53% to $35864.0 in 2023, then plunged by 368.59% to -$96326.0 in 2024.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered -$96326.0, $35864.0, and $2.4 million for Q1 2024, Q3 2023, and Q1 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 13.00 Mn |
| 10 | Universe Pharmaceuticals | 2.93 Mn | -26.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -96,326.00 |
| Sep 30, 2023 | 35,864.00 |
| Mar 31, 2023 | 2.44 Mn |
| Sep 30, 2022 | 2.44 Mn |